Concepedia

David B. Olsen

DB

147

Publications

9.3K

Citations

47

H-Index

1975

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Rigshospitalet

University of Copenhagen

WuXi AppTec (China)

David B. Olsen is an author at United States Military Academy specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1975–2024

147

Publications

147

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

Steven D. Young, Susan F. Britcher, L O Tran et al. · Antimicrobial Agents and Chemotherapy · 1995 · 480 citations · Full text

Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes

Wolfgang A. Pieken, David B. Olsen, Fritz Benseler et al. · Science · 1991 · 467 citations

Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs

Steven S. Carroll, Joanne E. Tomassini, Michele Bosserman et al. · Journal of Biological Chemistry · 2003 · 336 citations · Full text

, , +17

Erythrocyte and the Regulation of Human Skeletal Muscle Blood Flow and Oxygen Delivery

José González‐Alonso, David B. Olsen, Bengt Saltin · Circulation Research · 2002 · 328 citations · Full text

, , +13

Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

Giovanni Migliaccio, Joanne E. Tomassini, Steven S. Carroll et al. · Journal of Biological Chemistry · 2003 · 324 citations · Full text

Rows per page

1–5 of 147